University of Kansas Cancer Center
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
University of Kansas Cancer CenterDivision of Hematologic Malignancies and Cellular Therapeutics
4000 Cambridge St.
Kansas City, , 66160
Kansas City, , 66160
Website : https://www.kucancercenter.org/cancer/cancer-treatments/blood-marrow-transplant
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Number performed | 39 | 57 | 90 | 116 | - |
Program Director
| Name | Phone |
|---|---|
| Mia Strusz, MSHA | (913) 588-6030 |
Medical Director
| Name | Phone |
|---|---|
| Joseph McGuirk, DO | (913) 588-6030 |
Physician
| Name | Phone |
|---|---|
| Haitham Abdelhakim, MD | (913) 588-6030 |
| Sunil Abhyankar, MD | (913) 588-6030 |
| Nausheen Ahmed, MD | (913) 588-6030 |
| Rajat Bansal, MD | (913) 588-6030 |
| Forat Lutfi, MD | (913) 588-6030 |
| Leyla Shune, MD | (913) 588-6030 |
| Anurag Singh, MD | (913) 588-6030 |
| Muhammad Umair Mushtaq, MD | (913) 588-6030 |
Coordinator
| Name | Phone |
|---|---|
| Allison Appenfeller, RN, BSN, OCN | (913) 588-9821 |
| Sarah Bromert, RN, BSN | (913) 588-9821 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)